AllAnalyst Report
Morningstar•February 26, 2021
Morningstar•February 26, 2021McKesson Corporation: McKesson’s Second Consecutive Strong Quarter Exudes Confidence; Raising FVE to $198
Summary
McKesson is the largest leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada. Through acquisition and joint ventures McKesson also runs the fourth-largest pharmacy chain and provides techno
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: Humana Inc.Apr 24, 2024 •
HUM
- Analyst Report: Thermo Fisher Scientific Inc.Apr 24, 2024 •
TMO
- Analyst Report: Cardinal Health, Inc.Apr 24, 2024 •
CAH
- Analyst Report: Quest Diagnostics IncorporatedApr 24, 2024 •
DGX
- CI: Raising target price to $370.00Apr 24, 2024 •
CI
Analyst Profile
Soo Romanoff
Equity AnalystTancrede Fulop, CFA, is an equity analyst for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He covers European utilities.Before joining Morningstar in early 2017, Fulop worked for Schlumberger Business Consulting as a financial and economist analyst. Previously, he was a senior research associate covering European utilities for Raymond James from 2011 to 2015.Fulop holds a master’s degree in finance from the University Paris II Pantheon-Assas. He also holds the Chartered Financial Analyst® designation.